Novavax vaccine shows resilient defense against symptomatic COVID-19 despite Omicron challenge

Recent study assesses NVX-CoV2373 vaccine’s effectiveness against Omicron variant. Findings show decreased efficacy over four months, but stable protection against symptomatic COVID-19.

Alkermes fends off generic versions of Vivitrol until 2027 – Pharmaceutical Technology

Vivitrol is Alkermes’s highest-grossing drug and is projected to generate up to $410m in sales in 2023. Image Credit: PanuShot / Shutterstock. Alkermes has settled

August 31, 2023

Viral hepatitis is a silent killer. It can’t be eliminated if it isn’t tracked

Before the Covid-19 pandemic, viral hepatitis killed more people in the United States than all 60 other reportable infectious diseases combined, including HIV, pneumonia, and

April 17, 2024

Is morning exercise the key to dodging diabetes?

Harvard researchers find that morning and afternoon physical activity significantly lowers the risk of developing type 2 diabetes, but evening activity shows no such benefit.

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.